Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment.  The BEta-blocker STrategy plus ICD trial. | Zendy

Antonio Raviele | Zendy; Maria Grazia Bongiorni | Zendy; Michele Brignole | Zendy; Riccardo Cappato | Zendy; Alessandro Capucci | Zendy; F GAITA | Zendy; M GULIZIA | Zendy; S Mangiameli | Zendy; A. S. Montenero | Zendy; Roberto F.E. Pedretti | Zendy

Open Access

Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment. The BEta-blocker STrategy plus ICD trial.

Author(s) -

Antonio Raviele,

Maria Grazia Bongiorni,

Michele Brignole,

Riccardo Cappato,

Alessandro Capucci,

F GAITA,

M GULIZIA,

S Mangiameli,

A. S. Montenero,

Roberto F.E. Pedretti

Publication year - 2005

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1016/j.eupc.2005.03.003

Subject(s) - medicine , myocardial infarction , cardiology , ejection fraction , sudden cardiac death , implantable cardioverter defibrillator , metoprolol , beta blocker , heart failure

This multicentre prospective randomised trial was undertaken to evaluate the usefulness of an electrophysiological study (EPS)-guided/implantable cardioverter defibrillator (ICD) strategy in patients at high risk of sudden death (SD) early after myocardial infarction (MI). Previous studies have shown the benefits of such a strategy only in high-risk patients late after MI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research